Kevin P. Rosenblatt,Prem P. Gurnani,David W. Lasecki
申请号：
US14664433
公开号：
US20150265628A1
申请日:
2015.03.20
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Several embodiments disclosed herein relate to methods for calculating a dosing regimen that is tailored specifically to the genetic and metabolic profile of a particular patient. In some embodiments, the dosing regimen is related to administration of the antipsychotic drug clozapine, and the tailoring of the regimen reduces risk of adverse side effects.
